Table 2.
Distribution of antimicrobial groups as per indication of use.
| Antimicrobial groups | Treatment of infection n (%) | Medical prophylaxis n (%) | Surgical prophylaxis n (%) | Total |
|---|---|---|---|---|
| Beta-Lactams (Penicillins & Cephalosporins) | 322 (43.5) | 60 (8.1) | 359 (48.4) | 741 |
| Protein Synthesis Inhibitors (Tetracyclines, Aminoglycosides Macrolides & Oxazolidones) | 210 (44.4) | 26 (5.5) | 237 (50.1) | 473 |
| Anti TB & Leprosy | 195 (100) | 0 (0) | 0 (0) | 195 |
| Antiprotozoal & Anti Helminths | 74 (44.6) | 40 (24.1) | 52 (31.3) | 166 |
| Fluoroquinolones | 90 (68.7) | 15 (11.5) | 26 (19.8) | 131 |
| Antivirals | 107 (97.3) | 2 (1.8) | 1 (0.9) | 110 |
| PABA Synthesis Inhibitors (sulphonamides) | 36 (62.1) | 20 (34.5) | 2 (3.4) | 58 |
| Antifungals | 38 (79.2) | 7 (14.6) | 3 (6.2) | 48 |
| Polypeptide antibiotics | 13 (92.9) | 0 (0) | 1 (7.1) | 14 |
| Antimalarial | 4 (100) | 0 (0) | 0 (0) | 4 |